Brechue W F, Kinne-Saffran E, Kinne R K, Maren T H
Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville 32610.
Biochim Biophys Acta. 1991 Jul 22;1066(2):201-7. doi: 10.1016/0005-2736(91)90187-d.
A null allele at the mouse Car 2 locus was induced by ethylnitrosurea; mice homozygous for the new allele lack the carbonic anhydrase (CA)-II isoenzyme. The expression of this genetic lesion was investigated by: (1) using tissue fractionation techniques to determine localization and activity of CA in the kidney, and (2) examining renal response to CA inhibition in CA-II deficient mice (CAD), in normal (N) mice and in heterozygous litter mates (LM). N and LM mice had CA activity in proximal tubule brush border membranes and cytosol. CA activity was also localized to membranes and cytosol of the outer medullary region. CAD mice lacked cytosolic activity but had normal CA activity in all membranes examined. All membrane associated CA had 2-8-fold lower sulfonamide sensitivity than cytosolic CA. These inhibition characteristics suggest that the membrane enzyme is CA-IV. Baseline urinary excretion of Na+, K+, and HCO3- was similar in all groups. Urine pH and Cl- excretion were higher and titratable acid output was lower in CAD mice. Inhibition of CA (methazolamide, 25 mg/kg) led in all groups to equivalent increments of urine pH, urine flow, and HCO3-, Na+, and K+ excretion. Cl- excretion was unchanged. Thus the extent of the genetic deficiency of CA-II mice extends to the kidney cytosol but does not alter membrane localization or levels of CA, probably CA-IV. The similar response to CA inhibition in CAD mice suggests that CA-IV, the membrane bound isoenzyme is the important isoenzyme in proximal tubule HCO3- reabsorption.
用乙基亚硝基脲诱导小鼠Car 2基因座产生无效等位基因;该新等位基因的纯合小鼠缺乏碳酸酐酶(CA)-II同工酶。通过以下方式研究了这种基因损伤的表现:(1)使用组织分级分离技术确定肾脏中CA的定位和活性,以及(2)检测CA-II缺陷小鼠(CAD)、正常(N)小鼠和杂合子同窝仔鼠(LM)对CA抑制的肾脏反应。N和LM小鼠在近端小管刷状缘膜和胞质溶胶中具有CA活性。CA活性也定位于外髓区域的膜和胞质溶胶中。CAD小鼠缺乏胞质溶胶活性,但在所检测的所有膜中具有正常的CA活性。所有与膜相关的CA对磺胺类药物的敏感性比胞质溶胶中的CA低2至8倍。这些抑制特性表明膜酶是CA-IV。所有组中Na+、K+和HCO3-的基线尿排泄相似。CAD小鼠的尿pH值和Cl-排泄较高,可滴定酸排出量较低。抑制CA(甲唑酰胺,25 mg/kg)在所有组中导致尿pH值、尿流量以及HCO3-、Na+和K+排泄等量增加。Cl-排泄未改变。因此,CA-II小鼠的基因缺陷程度延伸至肾脏胞质溶胶,但不改变膜定位或CA(可能是CA-IV)的水平。CAD小鼠对CA抑制的相似反应表明,膜结合同工酶CA-IV是近端小管HCO3-重吸收中的重要同工酶。